JP2023529152A5 - - Google Patents
Info
- Publication number
- JP2023529152A5 JP2023529152A5 JP2022574660A JP2022574660A JP2023529152A5 JP 2023529152 A5 JP2023529152 A5 JP 2023529152A5 JP 2022574660 A JP2022574660 A JP 2022574660A JP 2022574660 A JP2022574660 A JP 2022574660A JP 2023529152 A5 JP2023529152 A5 JP 2023529152A5
- Authority
- JP
- Japan
- Prior art keywords
- pharmaceutical composition
- composition according
- seq
- fragment
- virus
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202063035733P | 2020-06-06 | 2020-06-06 | |
| US63/035,733 | 2020-06-06 | ||
| PCT/US2021/036104 WO2021248111A1 (en) | 2020-06-06 | 2021-06-07 | Materials and methods for inhibiting a viral infection, including a coronavirus infection |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2023529152A JP2023529152A (ja) | 2023-07-07 |
| JP2023529152A5 true JP2023529152A5 (https=) | 2024-06-11 |
Family
ID=78831585
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022574660A Withdrawn JP2023529152A (ja) | 2020-06-06 | 2021-06-07 | コロナウイルス感染を含むウイルス感染を阻害するための物質および方法 |
Country Status (11)
| Country | Link |
|---|---|
| US (2) | US11826390B2 (https=) |
| EP (1) | EP4161558A4 (https=) |
| JP (1) | JP2023529152A (https=) |
| KR (1) | KR20230025853A (https=) |
| CN (1) | CN116133669A (https=) |
| AU (1) | AU2021286002A1 (https=) |
| BR (1) | BR112022024911A2 (https=) |
| CA (1) | CA3180737A1 (https=) |
| IL (1) | IL298401A (https=) |
| MX (1) | MX2022015439A (https=) |
| WO (1) | WO2021248111A1 (https=) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| MX2022006163A (es) * | 2019-11-26 | 2022-06-17 | Quorum Innovations Llc | Nuevas composiciones de barrera protectora y usos de las mismas. |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2002951270A0 (en) * | 2002-09-06 | 2002-09-19 | Vri Biomedical Ltd | Probiotic Bacterium and Methods of Use |
| WO2007040446A1 (en) | 2005-10-06 | 2007-04-12 | Probi Ab | Use of lactobacillus for treatment of autoimmune diseases |
| BRPI0822997A2 (pt) * | 2008-09-04 | 2015-06-23 | Om Pharma | Extratos imunomoduladores de bactérias lactobacillus e métodos para fabricação e uso dos mesmos |
| KR101378608B1 (ko) * | 2011-04-13 | 2014-03-27 | 씨제이제일제당 (주) | 바이러스 감염 억제 활성을 갖는 신규 분리한 락토바실러스 퍼멘텀 균주 |
| DK3324986T3 (da) * | 2015-07-20 | 2022-01-31 | Quorum Innovations Llc | Materialer og fremgangsmåder til forbedring af immunreaktioner og hud- og/eller slimhindebarrierefunktion |
| CA3176797A1 (en) * | 2020-05-06 | 2021-11-11 | Nicholas T. Monsul | Novel protein, and therapeutic and cosmetic uses thereof |
-
2021
- 2021-06-07 EP EP21816956.3A patent/EP4161558A4/en not_active Withdrawn
- 2021-06-07 CN CN202180059965.6A patent/CN116133669A/zh active Pending
- 2021-06-07 BR BR112022024911A patent/BR112022024911A2/pt unknown
- 2021-06-07 CA CA3180737A patent/CA3180737A1/en active Pending
- 2021-06-07 KR KR1020237000014A patent/KR20230025853A/ko active Pending
- 2021-06-07 MX MX2022015439A patent/MX2022015439A/es unknown
- 2021-06-07 AU AU2021286002A patent/AU2021286002A1/en not_active Abandoned
- 2021-06-07 US US17/418,440 patent/US11826390B2/en active Active
- 2021-06-07 WO PCT/US2021/036104 patent/WO2021248111A1/en not_active Ceased
- 2021-06-07 IL IL298401A patent/IL298401A/en unknown
- 2021-06-07 JP JP2022574660A patent/JP2023529152A/ja not_active Withdrawn
-
2023
- 2023-10-25 US US18/493,979 patent/US20240075083A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| RU2016109940A (ru) | Вакцина против бешенства | |
| EA201000085A1 (ru) | dsPHK, ПРЕДНАЗНАЧЕННАЯ ДЛЯ ЛЕЧЕНИЯ ВИРУСНОЙ ИНФЕКЦИИ | |
| Matveeva et al. | Mechanisms of oncolysis by paramyxovirus Sendai | |
| AR021876A1 (es) | Terapia de combinacion para vhc por induccion de ribavirina - interferon alfa pegilado | |
| NZ587105A (en) | Tissue protective peptides and peptide analogs for preventing and treating diseases and disorders associated with tissue damage | |
| TW201408309A (zh) | 用於治療ｂ型肝炎及ｄ型肝炎感染之方法 | |
| MXPA05005203A (es) | Vacuna contra vhc. | |
| JP2023529152A5 (https=) | ||
| JP5209462B2 (ja) | コンセンサスインターフェロンの使用方法 | |
| US8075877B2 (en) | Broad spectrum immune and antiviral gene modulation by oral interferon | |
| CN111714621A (zh) | 转铁蛋白、转铁蛋白受体及其抗体在制备抗SARS-CoV-2病毒的药物中的应用 | |
| CA2644670A1 (en) | Broad spectrum immune and antiviral gene modulation by oral interferon | |
| KR101802447B1 (ko) | 김치 및 된장 유래 젖산균을 유효성분으로 포함하는 인플루엔자 바이러스 예방 및 치료용 조성물 | |
| KR101329348B1 (ko) | 돼지 인터페론 알파-돼지 인터페론 감마를 동시 발현하는 재조합 아데노바이러스 | |
| JP2007516214A5 (https=) | ||
| Wiendl et al. | Multiple Sclerosis Therapy Consensus Group (MSTCG) | |
| JP2008503569A5 (https=) | ||
| MX2022004399A (es) | Metodos para tratar infecciones viricas por hepatitis delta. | |
| KR102616012B1 (ko) | 당화된 돼지 인터페론-알파를 발현하는 재조합 베큘로바이러스 | |
| KR100805996B1 (ko) | 항-바이러스 의약 및 항암 의약을 제조하기 위한파라폭스바이러스 오비스 균주의 용도 | |
| CN117460533A (zh) | 血管内皮抑制素在治疗和预防冠状病毒相关疾病中的应用 | |
| US20230277650A1 (en) | Use of a birnavirus for the treatment of a disease caused by varicella zoster virus (vzv) | |
| KR101077188B1 (ko) | 구제역 바이러스 억제를 위한 ｓｉＲＮＡ를 발현하는 재조합 아데노바이러스 | |
| JP2006515172A (ja) | パラポックスウイルス・オヴィスの組換えタンパク質およびそれ由来の医薬組成物 | |
| Carretti | Improving and addressing lymphocytes response against SARS-CoV-2 and its variants with intralveolar BCG administration |